Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482625
Status:
TERMINATED
Last Update Posted:
2014-10-16
First Post:
2007-06-04
Brief Title:
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Intraductal Papillary Mucinous Neoplasm of the Pancreas |
| Recurrent Pancreatic Cancer |
| Stage IA Pancreatic Cancer |
| Stage IB Pancreatic Cancer |
| Stage IIA Pancreatic Cancer |
| Stage IIB Pancreatic Cancer |
| Stage III Pancreatic Cancer |
Keywords: